BIOLASE CEO SHARES VISION FOR KINDLER, GENTLER DENTISTRY WITH CUSTOMERS AROUND THE WORLD

Rhea-AI Summary

BIOLASE (NASDAQ: BIOL) announced that CEO John Beaver is continuing the "CEO on the Go" initiative, aiming to gather feedback while promoting minimally invasive dentistry. This initiative involves visiting over 100 dentists globally, with 50 visits already completed as of May 2022. Beaver emphasized that over 70% of recent Waterlase sales were to new customers, showcasing the effectiveness of their education and training investments. BIOLASE is recognized for its patented dental laser technology, aimed at improving patient care and recovery times.

Positive

• Over 70% of Waterlase sales in the last year were to new customers.
• More than 100 dentist visits planned, indicating proactive customer engagement.
• Investment in education and training showing positive results in technology adoption.

Negative

• None.

"CEO on the Go" John Beaver visits with customers and future customers, gathering feedback and sharing BIOLASE's commitment to minimally-invasive dentistry for dentists & patients

LAKE FOREST, Calif., May 24, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, shared today that CEO John Beaver will continue his global "CEO on the Go" customer visit initiative throughout the year.

"The CEO on the Go program was created to get valued feedback from customers around the world, and help share our vision of creating kinder, gentler oral health care for dental professionals and their patients," said BIOLASE President and CEO John Beaver. "This program gives us direct feedback from dentists globally around how our products are delivering on this promise, and how we can continue to innovate on our market-leading dental laser technology.  I am always amazed at the benefits our Waterlase technology provides in real-life settings.  Recently, I watched a dentist use the Waterlase iPlus to remove 19 veneers in one sitting in less than 30 minutes! Without the laser, the dentist told me this would have been an-all day affair resulting in much more patient discomfort.  

"My travels this year have further confirmed my belief that what we are incorporating as strategy at BIOLASE today is accelerating the adoption curve of our game-changing technology.  With over 70% of our U.S. Waterlase sales being to new customers over the last twelve months, I am convinced that our investment in education, training and the Waterlase Exclusive Trial Program is working."

Through the "CEO on the Go" program, John has visited over 50 dentists and their respective teams to date.  Over 50 more visits are planned for the remainder of the year, throughout the U.S., with visits planned internationally in 2023.

To learn more about the "CEO on the Go" program and watch videos of these customer visits, go to biolase.com/ceo-on-the-go. 

About BIOLASE

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 301 patented and 32 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 43,300 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

For further information, please contact:

Investors:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-ceo-shares-vision-for-kindler-gentler-dentistry-with-customers-around-the-world-301553096.html

SOURCE BIOLASE, Inc.

FAQ

What is the CEO on the Go initiative by BIOLASE?

The CEO on the Go initiative involves CEO John Beaver visiting dentists worldwide to gather feedback and promote minimally invasive dental care.

How many dentist visits has BIOLASE CEO completed?

As of May 2022, BIOLASE CEO John Beaver has completed over 50 dentist visits, with plans for over 50 more visits this year.

What percentage of Waterlase sales were to new customers?

Over 70% of Waterlase sales in the last year were attributed to new customers.

When was the press release about BIOLASE's CEO initiative issued?

The press release was issued on May 24, 2022.

What is the primary goal of the CEO's customer visits?

The primary goal is to gather valued feedback from dentists and to share BIOLASE's vision for kinder, gentler oral health care.